Majid Anderesi

Majid Anderesi, MD, is a highly experienced medical professional with a background in ophthalmology and clinical research. He currently serves as the Vice President of Clinical and Medical Affairs at OcuTerra Therapeutics, a position he has held since April 2022.13

Prior to joining OcuTerra, Dr. Anderesi held several prominent positions at Novartis:

1. Global Medical Affairs Director for the Novartis Ophthalmology Franchise1
2. Worldwide Medical Affairs Director, Ophthalmology Franchise and Beovu4
3. Worldwide Medical Affairs Director, Immunology Franchise5

Dr. Anderesi's career also includes roles at other pharmaceutical companies:

• Group Clinical Director Ophthalmology at Genentech (2015-2019)4
• Global Clinical Leader for Bayer's "Biological Products," where he was responsible for Gamunex (IVIG)2

With over twenty years of experience in drug development and medical affairs, Dr. Anderesi brings deep expertise in retinal clinical trials to his current role at OcuTerra Therapeutics.3 He received his MD in Medicine from Justus-Liebig-Universität Giessen.